Effects of OLP on allergic symptoms
OLP
SECONDARY
Baseline data revealed no differences with respect to the different arms (see Table Outcomes at 4 weeks endpoint for primary outcome measure CSMS (change scores from pre to post, bars represent standard errors).Outcome at 4 weeks endpoint (mean ± standard deviations of change scores).TNSS results revealed improved scores for OLP relative to DBP and TAU (change scores for last 12 h; GEE: Wald xOutcomes at 4 weeks endpoint for secondary outcome measure TNSS (change scores from pre to post, bars represent standard errors).We further followed our a priori hypothesis and performed an analysis to test whether the OLP condition is superior to TAU (Wilcoxon test). Results revealed that OLP improved more than TAU for CSMS of the last two weeks with a medium effect size (Z = − 2.17, When comparing OLP with DBP we found that OLP was superior to DBP with respect to TNSS (12 h, Z = − 2.68, 